MINNEAPOLIS, MN, US, Aug. 25, 2021 (World NEWSWIRE) — PetVivo Holdings, Inc. (NASDAQ: PETV) (the “Enterprise”) an emerging biomedical machine firm centered on the commercialization of progressive professional medical therapeutics for pets is happy to announce that Ann Zieser, DVM has accepted a place with the Corporation as its new Senior Technical Veterinarian.
“We are extremely excited to have Ann be part of the PetVivo staff and offer her substantial veterinary know-how to further more the eyesight of PetVivo and support other vets in the cure of companion animals.” said John Lai, Main Government Officer of PetVivo Holdings, Inc. “Dr. Zieser provides a prosperity of encounter to our team as an pro in veterinary medication and the therapeutic treatment method of cats, puppies and horses.”
Dr. Zieser started her job as a companion animal practitioner at Middleton Veterinary Medical center (“MVH”) found exterior Madison, Wisconsin. Thirty-just one several years later on she continues to work at MVH dealing with companion pet dogs and cats doing diagnostics, internal medication, radiology, surgery, dentistry to title just a couple of disciplines. Dr. Zieser has even more contributed to the veterinary neighborhood as the secretary of the local Dane County Veterinary Health-related Affiliation. Pursuing numerous different volunteer positions inside of the Wisconsin Veterinary Healthcare Association, Dr. Zieser elevated her participation by accepting the function as President-Elect of the Wisconsin Veterinary Health-related Association. Dr. Zieser has additional climbed from local and condition organized veterinary medicine into the nationwide arena as the American Veterinary Health care Association alternate delegate and then delegate for the point out of Wisconsin. Dr. Zieser has a degree in biochemistry from the University of Wisconsin – Madison and a Doctorate in Veterinary Drugs from UW-Wisconsin University of Veterinary Medication.
“I am thrilled to be part of the PetVivo workforce and participate in the effort to introduce the therapeutic advantages of SPRYNG™ to companion animals suffering from osteoarthritis and other lameness afflictions,” claimed Dr. Zieser. “I am self-assured that SPRYNG™ will greatly enhance the lives of companion animals, as nicely as their entrepreneurs.”
About PetVivo Holdings, Inc.
PetVivo Holdings Inc. (NASDAQ: PETV) is an rising biomedical unit organization now targeted on the manufacturing, commercialization and licensing of progressive health care devices and therapeutics for companion animals. The Firm’s method is to leverage human therapies for the therapy of companion animals in a funds and time successful way. A essential part of this technique is the accelerated timeline to revenues for veterinary health care products, which enter the current market a great deal before than additional stringently regulated prescribed drugs and biologics.
PetVivo has a pipeline of seventeen products and solutions for the therapy of animals and people today. A portfolio of 20-1 patents shields the Firm’s biomaterials, goods, production procedures and solutions of use. The Company’s direct product or service SPRYNG, a veterinarian-administered, intraarticular injection for the cure of osteoarthritis in puppies and horses, is scheduled for expanded professional sale later on this year.
John Lai, CEO PetVivo Holdings, Inc. Electronic mail: [email protected] (952) 405-6216
Ahead-Wanting commercial Statements:
The foregoing substance may possibly contain “forward-seeking statements” in the indicating of Area 27A of the Securities Act of 1933 and Section 21E of the Securities Trade Act of 1934, every as amended. Ahead-looking statements involve all statements that do not relate exclusively to historic or current points, such as devoid of limitation the Company’s proposed improvement and commercial timelines, and can be identified by the use of words this kind of as “may,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “believe,” “potential,” “should,” “continue” or the adverse versions of these text or other equivalent phrases. Forward-hunting statements are not ensures of foreseeable future actions or efficiency. These ahead-hunting statements, such as the potential listing of the Company’s prevalent stock on Nasdaq, are based mostly on details at this time available the Organization and its present-day programs or anticipations and are matter to a range of uncertainties and pitfalls that could drastically affect current strategies. Hazards relating to the Company’s enterprise are explained in detail in the Company’s Yearly Report on Kind 10-K for the 12 months ended March 31, 2020 and other periodic and existing stories filed with the Securities and Exchange Commission. The Enterprise is less than no obligation to, and expressly disclaims any these kinds of obligation to, update or alter its ahead-searching statements, irrespective of whether as a end result of new details, future events or or else.
Copyright 2021 GlobeNewswire, Inc.